Vic pharma manufacturer expands operations
Melbourne-based company Australian Pharmaceutical Manufacturers (APM), a division of Pact Group, has opened expanded operations in the suburb of Keysborough, allowing the company to increase exports and create 44 new local jobs.
With support from the Victorian Government, the $6.9 million upgrade will allow APM, which offers contract manufacturing and packaging services for products including vitamin and mineral supplements, to take on more work from existing clients and increase its reach across Asia.
“The Victorian Government is busy walking the talk, actually investing in supporting manufacturing and breathing life into projects that grow employment and help Victorian business succeed,” said Pact Group Chairman Raphael Geminder.
“We all win when we get great collaboration between government and industry, and APM ... couldn’t have made this project come to life without the Victorian Government’s help.”
APM is the latest company to invest in Victoria’s medical technologies and pharmaceuticals sector, following recent significant investments by Praxis, CSL, Nutribiotech and Aspen Australia. This investment is a further boost to Victoria’s manufacturing industry, which contributes more than $30 billion to the economy and employs more than 270,000 people.
“Pharmaceuticals are Victoria’s highest-value manufactured export product, worth $1.5 billion to the state’s economy each year,” said Victorian Member for Keysborough and Minister for Jobs, Innovation and Trade Martin Pakula.
“We’re proud to support APM in their expansion efforts, helping them to capture growing international demand for Australian-manufactured products and create new local jobs.”
Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.
Stem cell experiments conducted in space
Scientists are one step closer to manufacturing stem cells in space — which could speed up...
Plug-and-play test evaluates T cell immunotherapy effectiveness
The plug-and-play test enables real-time monitoring of T cells that have been engineered to fight...
Common heart medicine may be causing depression
Beta blockers are unlikely to be needed for heart attack patients who have a normal pumping...